Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹100 & Lump. ₹500

AUM (Fund size)

533 Cr

Lock In Period

N/A

Expense Ratio

2.37

Benchmark

BSE Healthcare Total Return

Exit Load

In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed/ switched-out within 1 month from the date of allotment.No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment.

Summary

Latest details for WhiteOak Capital Pharma and Healthcare Fund Growth include a 13.350 NAV as of Apr 01,2026 and returns since inception of --%. Minimum investments start at SIP ₹100. The WhiteOak Capital Pharma and Healthcare Fund Growth AUM is ₹533 Cr, with a lock-in of N/A years, expense ratio of 2.37%, and benchmark BSE Healthcare Total Return. Exit load is - In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed/ switched-out within 1 month from the date of allotment.No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment.. In the growth review for 1M Month/Year, the fund recorded -3.89% returns, against a category average of -1.57% and a category best of 7.65%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-3.89-1.577.65
6M-0.980.4150.70
1Y5.093.60162.75
3Y0.0010.07221.83

Portfolio Analysis

  • Equity: 93.86%
  • Debt: 6.14%
  • Others
As on: 2026-02-28
View allocation % by

1. Sun Pharmaceutical Industries Limited11.85%
2. JB Chemicals & Pharmaceuticals Limited9.44%
3. Lupin Limited5.29%
4. Divi's Laboratories Limited4.74%
5. Laurus Labs Limited4.33%
6. Sai Life Sciences Limited2.46%
7. Ajanta Pharma Limited2.35%
8. Corona Remedies Limited2.31%
9. Acutaas Chemicals Limited2.25%
10. IPCA Laboratories Limited1.96%
11. Pfizer Limited1.73%
12. Emcure Pharmaceuticals Limited1.70%
13. AstraZeneca Pharma India Limited1.48%
14. Neuland Laboratories Limited1.46%
15. Aurobindo Pharma Limited1.32%
16. Strides Pharma Science Limited1.18%
17. Supriya Lifescience Limited0.84%
18. Sudeep Pharma Limited0.75%
19. Zota Health Care Limited0.66%
20. Aarti Pharmalabs Limited0.61%
21. Abbott India Limited0.58%
22. Alkem Laboratories Limited0.54%
23. Shilpa Medicare Limited0.52%
24. Zydus Lifesciences Limited0.49%
25. Torrent Pharmaceuticals Limited0.29%
26. Orchid Pharma Limited0.26%

1. Max Healthcare Institute Limited5.88%
2. Fortis Healthcare Limited5.54%
3. Apollo Hospitals Enterprise Limited5.08%
4. Krishna Institute Of Medical Sciences Limited3.95%
5. Narayana Hrudayalaya Limited1.94%
6. Kovai Medical Center and Hospital Limited1.32%
7. Dr. Lal Path Labs Limited1.17%
8. Vijaya Diagnostic Centre Limited1.14%
9. Thyrocare Technologies Limited0.99%
10. Dr.Agarwals Eye Hospital Limited0.33%

1. Shaily Engineering Plastics Limited1.78%

1. Navin Fluorine International Limited1.60%

1. Aether Industries Limited1.26%
2. Tatva Chintan Pharma Chem Limited0.20%

About Fund

WhiteOak Capital Pharma and Healthcare Fund Growth managed by WhiteOak Capital Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹533 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.37. Under the expert guidance of Ramesh Mantri ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Peer Comparison

Fund Name1Y3Y
This FundHDFC Pharma and Healthcare Fund Growth6.6390
This FundAditya Birla Sun Life Transportation and Logistics Fund Growth7.00160
This FundWhiteOak Capital Pharma and Healthcare Fund Growth5.08590
This FundICICI Prudential PSU Equity Fund Growth4.354596.0539
This FundNippon India Taiwan Equity Fund Growth159.122208.7015

FAQs

WhiteOak Capital Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of WhiteOak Capital Pharma and Healthcare Fund Growth is 2.37. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

WhiteOak Capital Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : -3.89%
  • 6 Months : -0.98%
  • 1 Year : 5.09%
  • 3 Years : 0.00%
Returns of WhiteOak Capital Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 13.350 as on Apr 01,2026. Since inception, the return has been 0.00%.

You can invest in WhiteOak Capital Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of WhiteOak Capital Pharma and Healthcare Fund Growth is ₹533 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in WhiteOak Capital Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500